Lev-Ran S[Author] - Search Results

Year	Number of Results
1998	1
2003	1
2007	1
2011	9
2012	14
2013	10
2014	8
2015	6
2016	6
2017	10
2018	14
2019	7
2020	5
2021	7
2022	7
2023	5
2024	0

1

Does cannabis use increase anxiety disorders? A literature review.

Shalit N, Lev-Ran S. Shalit N, et al. Among authors: lev ran s. Curr Opin Psychiatry. 2020 Jan;33(1):8-13. doi: 10.1097/YCO.0000000000000560. Curr Opin Psychiatry. 2020. PMID: 31592815 Review.

2

[Motivational interviewing in health care].

Lev-Ran S, Nitzan U. Lev-Ran S, et al. Harefuah. 2011 Sep;150(9):733-6, 749. Harefuah. 2011. PMID: 22026060 Review. Hebrew.

3

Negative experiences of patients using medicinal cannabis: A systematic review of qualitative studies.

Gliksberg O, Kushnir T, Sznitman SR, Lev-Ran S, Brill S, Amit BH, Feingold D. Gliksberg O, et al. Among authors: lev ran s. J Clin Nurs. 2023 Sep;32(17-18):5607-5618. doi: 10.1111/jocn.16653. Epub 2023 Feb 19. J Clin Nurs. 2023. PMID: 36807590 Review.

4

Pharmacotherapy of alcohol use disorders and concurrent psychiatric disorders: a review.

Lev-Ran S, Balchand K, Lefebvre L, Araki KF, Le Foll B. Lev-Ran S, et al. Can J Psychiatry. 2012 Jun;57(6):342-9. doi: 10.1177/070674371205700603. Can J Psychiatry. 2012. PMID: 22682571 Review.

5

Examining the ethical boundaries of harm reduction: from addictions to general psychiatry.

Lev-Ran S, Nitzan U, Fennig S. Lev-Ran S, et al. Isr J Psychiatry Relat Sci. 2014;51(3):175-80. Isr J Psychiatry Relat Sci. 2014. PMID: 25618280 Free article. Review.

6

The association between cannabis use and depression: a systematic review and meta-analysis of longitudinal studies.

Lev-Ran S, Roerecke M, Le Foll B, George TP, McKenzie K, Rehm J. Lev-Ran S, et al. Psychol Med. 2014 Mar;44(4):797-810. doi: 10.1017/S0033291713001438. Psychol Med. 2014. PMID: 23795762 Review.

7

Neurocognitive functioning and cannabis use in schizophrenia.

Segev A, Lev-Ran S. Segev A, et al. Among authors: lev ran s. Curr Pharm Des. 2012;18(32):4999-5007. doi: 10.2174/138161212802884799. Curr Pharm Des. 2012. PMID: 22716156 Review.

8

Cannabinoids for the treatment of mental disorders.

Feingold D, Lev-Ran S. Feingold D, et al. Among authors: lev ran s. Lancet Psychiatry. 2020 Feb;7(2):126-127. doi: 10.1016/S2215-0366(19)30523-1. Lancet Psychiatry. 2020. PMID: 31981534 No abstract available.

9

The association between type of trauma, level of exposure and addiction.

Levin Y, Lev Bar-Or R, Forer R, Vaserman M, Kor A, Lev-Ran S. Levin Y, et al. Among authors: lev ran s. Addict Behav. 2021 Jul;118:106889. doi: 10.1016/j.addbeh.2021.106889. Epub 2021 Mar 9. Addict Behav. 2021. PMID: 33735776

10

Why Switch? - Motivations for Self-Substitution of Illegal Drugs.

Shapira B, Berkovitz R, Rosca P, Lev-Ran S, Kaptsan A, Neumark Y. Shapira B, et al. Among authors: lev ran s. Subst Use Misuse. 2021;56(5):627-638. doi: 10.1080/10826084.2021.1887246. Epub 2021 Mar 4. Subst Use Misuse. 2021. PMID: 33663337

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

91 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

91 results

Results by year